Abstract

There is an urgent need for animal models to study SARS-CoV-2 pathogenicity. Here, we generate and characterize a novel mouse-adapted SARS-CoV-2 strain, MASCp36, that causes severe respiratory symptoms, and mortality. Our model exhibits age- and gender-related mortality akin to severe COVID-19. Deep sequencing identified three amino acid substitutions, N501Y, Q493H, and K417N, at the receptor binding domain (RBD) of MASCp36, during in vivo passaging. All three RBD mutations significantly enhance binding affinity to its endogenous receptor, ACE2. Cryo-electron microscopy analysis of human ACE2 (hACE2), or mouse ACE2 (mACE2), in complex with the RBD of MASCp36, at 3.1 to 3.7 Å resolution, reveals the molecular basis for the receptor-binding switch. N501Y and Q493H enhance the binding affinity to hACE2, whereas triple mutations at N501Y/Q493H/K417N decrease affinity and reduce infectivity of MASCp36. Our study provides a platform for studying SARS-CoV-2 pathogenesis, and unveils the molecular mechanism for its rapid adaptation and evolution.

In this study, Qin et al. present a murine-adapted SARS-CoV-2 strain, MASCp36, as a model for studying the pathogenicity, evolution and adaptation of the virus to human and animal hosts.

Details

Title
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
Author
Sun Shihui 1   VIAFID ORCID Logo  ; Gu Hongjing 1 ; Cao Lei 2 ; Chen, Qi 1 ; Ye Qing 1 ; Yang, Guan 3 ; Rui-Ting, Li 1 ; Fan Hang 1   VIAFID ORCID Logo  ; Yong-Qiang, Deng 1   VIAFID ORCID Logo  ; Song, Xiaopeng 3 ; Qi Yini 3 ; Li, Min 1 ; Lan, Jun 2 ; Feng, Rui 2 ; Guo, Yan 1 ; Zhu, Na 4   VIAFID ORCID Logo  ; Qin Si 1 ; Wang, Lei 2 ; Yi-Fei, Zhang 1 ; Zhou, Chao 1   VIAFID ORCID Logo  ; Zhao Lingna 1 ; Chen, Yuehong 1 ; Shen, Meng 1 ; Cui Yujun 1 ; Yang, Xiao 3   VIAFID ORCID Logo  ; Wang Xinquan 5   VIAFID ORCID Logo  ; Tan, Wenjie 4   VIAFID ORCID Logo  ; Wang, Hui 1 ; Wang Xiangxi 2   VIAFID ORCID Logo  ; Cheng-Feng, Qin 6   VIAFID ORCID Logo 

 Beijing Institute of Microbiology and Epidemiology, AMMS, State Key Laboratory of Pathogen and Biosecurity, Beijing, China (GRID:grid.410740.6) (ISNI:0000 0004 1803 4911) 
 Chinese Academy of Sciences, CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309) 
 Beijing Institute of Lifeomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing, China (GRID:grid.419611.a) (ISNI:0000 0004 0457 9072) 
 Chinese Center for Disease Control and Prevention (China CDC), National Institute for Viral Disease Control and Prevention, Beijing, China (GRID:grid.198530.6) (ISNI:0000 0000 8803 2373) 
 Tsinghua University, The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life Sciences, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178) 
 Beijing Institute of Microbiology and Epidemiology, AMMS, State Key Laboratory of Pathogen and Biosecurity, Beijing, China (GRID:grid.410740.6) (ISNI:0000 0004 1803 4911); Chinese Academy of Medical Sciences, Research Unit of Discovery and Tracing of Natural Focus Diseases, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2576737593
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.